Company Information

IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE125.450.5 (+0.4 %)
PREV CLOSE ( ) 124.95
OPEN PRICE ( ) 124.10
BID PRICE (QTY) 125.40 (20)
OFFER PRICE (QTY) 125.74 (24)
VOLUME 16486
TODAY'S LOW / HIGH ( )123.65 126.06
52 WK LOW / HIGH ( )63.4 138.25
NSE125.651.3 (+1.05 %)
PREV CLOSE( ) 124.35
OPEN PRICE ( ) 124.35
BID PRICE (QTY) 125.60 (1155)
OFFER PRICE (QTY) 125.70 (200)
VOLUME 295430
TODAY'S LOW / HIGH( ) 123.75 126.35
52 WK LOW / HIGH ( )63 138.45
ChairmanN R Munjal
Managing DirectorN R Munjal
Company SecretaryPardeep Verma
Executive DirectorRishav Mehta
Sahil Munjal
Joint Managing DirectorHimanshu jain
Non Executive Independent DirectorS P Sharma
Neerja Chathley
Ashwani Vig
Rajinder Kumar Gupta
Incorporation Year : 04-01 1995

Registered Office :

Address : S C O 850,Shivalik Enclave, N A C,Manimajra Chandigarh,
Union Territory-160101 .

Phone : 0172 5061850 / 2730920

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.